# FAKNOSTICS, LLC: Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | FAKNOSTICS, LLC |
| Location | PHOENIX, AZ |
| Project | Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis |
| Project number | 5R42HL162392-04 |
| Mechanism | R42 |
| Institute | National Heart Lung and Blood Institute |
| Award | $662,561 |
| Awarded | 2026-09-04 |
| Project period | 2022-08-10 to 2027-07-31 |
| UEI | TK5AKDP8CSZ7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11400394). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.